Clinical Trials Browser

Phase 2 × NETWORK × Fenretinide × Clear all

NCT00003223 2012-07-24

SWOG-9507, Fenretinide in Treating Patients With Neoplasia of the Mouth

Phase 2 Terminated

Head and Neck Neoplasms, Mouth Neoplasms